MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Leukemia, Hematologic, Blood
Gamida Cell Ltd.(NASDAQ: GMDA)*
Organization & Developments: Gamida Cell
Parents
Gamida Cell Ltd.(NASDAQ: GMDA)*
Children
*Cord blood-based NiCord® cell therapy for the treatment of sickle cell disease and thalassemia
*Gamida Cell Ltd. (NASDAQ: GMDA) is a biotech company focused on the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases.
*Joint venture with Teva as an alternative allogeneic therapy for patients with blood cancers such as leukemia and lymphoma
*StemEx cord blood stem cell therapy for blood cancers
2020: Greenlighting Gamida Cell
2021: Gamida Cell: Buying The Dip
2021: Gamida: Catalysts Ahead, Looks Interesting
2022: Gamida Cell (GMDA) Investor Presentation - Slideshow_ seekingalpha.com
2023: Gamida: The Die Is Now Cast_seekingalpha.com
Jumps
*Key People: Gamida Cell
Finance & Acquisitions: Gamida Cell